News Headlines Article

Prices Cut for Cervical Cancer Vaccines in Poor Countries
New York Times

The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world’s poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major cancer killer. Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries.

But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

Commands